Format

Send to

Choose Destination
Br J Hosp Med. 1993 May 19-Jun 1;49(10):710-1, 714-5.

Advanced prostate cancer: what's new in hormonal manipulation?

Author information

1
Department of Urology, Southmead Hospital, Bristol.

Abstract

Prostate cancer is the second most common cause of male cancer deaths in the UK. It is one of the few hormone-sensitive cancers and androgen ablation produces subjective and objective tumour regression in 70-80% of patients for a variable period. Orchidectomy remains the gold standard for treatment although there is an increasing number of equally effective medical alternatives.

Comment in

PMID:
7686805
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center